CRL vs MGM · rev $2.00B vs P/E 64, rev $4.45B
Charles River Laboratories (CRL) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
CRL currently screens at market cap $7.78B. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the CRL and MGM stock pages for the full models.
Not investment advice.